Create Account
C
Moderna, Inc.
MRNA
NASDAQ
$171.18 -$0.63-0.37% Volume2,818,023 08/12/2022 4:00PM Eastern Quotes delayed
Recommendation
Hold
Prev Close
$171.18
Avg Vol (90D)
5,555,105
Market Cap
$66.97B
Dividend & Yield
--
52-Week Range
$115.61 - $464.85
P/E (TTM)
5.22
EPS (TTM)
$32.81
My Lists My Alerts
Report
Rating
Reward
B
Good
Risk
D+
Weak
Rating Factors
Growth Index
Good
Efficiency Index
Good
Solvency Index
Excellent
Total Return Index
Fair
Volatility Index
Weak
Dividend Index
--
Headlines
Moderna, Inc. (NASDAQ:MRNA) Shares Bought by Csenge Advisory Group
8/13/2022 - Ticker Report
Moderna, Inc. (NASDAQ:MRNA) Insider Sells $383,606.20 in Stock
8/13/2022 - Ticker Report
CDC Admits It Gave False Information About COVID-19 Vaccine Surveillance
8/12/2022 - Zero Hedge
Principal Financial Group Inc. Cuts Position in Moderna, Inc. (NASDAQ:MRNA)
8/12/2022 - Zolmax
Moderna - Not Your Hot-Tip-From-Your-Brother-In-Law Biotech Stock
8/12/2022 - Forbes: Money
Lincoln National Corp Trims Holdings in Moderna, Inc. (NASDAQ:MRNA)
8/12/2022 - Zolmax
Here's how much I'd have now if I'd invested GBP1k in Scottish Mortgage shares 5 years ago!
8/12/2022 - The Motley Fool UK
3 Best Funds for Aggressive Investors
8/11/2022 - InvestorPlace
The 21 Top S&P 500 Stocks Since the Bear-Market Bottom
8/11/2022 - Kiplinger Personal Finance
Moderna CEO compares COVID-19 vaccines to iPhones, saying you'll probably be getting a new version each year
8/11/2022 - Insider: Finance
Is Baillie Gifford Losing Confidence in Tesla (TSLA) Stock?
8/11/2022 - InvestorPlace
Sentencing set for Bay Area naturopath who sold fake COVID-19 vaccine cards
8/11/2022 - The Mercury News: Health
Global Multiple Sclerosis Drugs Market Size Projected To Reach $33 Billion By 2029
8/11/2022 - PR Newswire
'Like an iPhone': Moderna CEO eyes future with annual vaccine for multiple viruses
8/11/2022 - CNN.com - Video
Moderna, Inc. (NASDAQ:MRNA) Shares Bought by Scotia Capital Inc.
8/11/2022 - Ticker Report
The story of a vaccine: how Moderna's big bet played out
8/11/2022 - ireland.com: Business
Wealthspire Advisors LLC Purchases New Shares in Moderna, Inc. (NASDAQ:MRNA)
8/10/2022 - Zolmax
What to Watch for on the TSX Today
8/10/2022 - Motley Fool Canada
The Scottish Mortgage share price is on the up! Here's why I'd buy
8/10/2022 - The Motley Fool UK
With Growth Slowing, Is Moderna Stock Still Worth A Look?
8/10/2022 - Forbes.com Market News
Oppenheimer Comments on Moderna, Inc.'s FY2022 Earnings (NASDAQ:MRNA)
8/10/2022 - Zolmax
FY2022 Earnings Forecast for Moderna, Inc. Issued By SVB Leerink (NASDAQ:MRNA)
8/10/2022 - Ticker Report
Q3 2022 EPS Estimates for Moderna, Inc. Decreased by Analyst (NASDAQ:MRNA)
8/10/2022 - Ticker Report
Dr. Anthony Fauci stops in Seattle for Fred Hutch Q&A, throws first pitch at Mariners game
8/10/2022 - GeekWire
Pfizer and Moderna Take Different Paths as Vaccine Boom Ends
8/9/2022 - MarketWatch.com - GOOG
Income Statement
Total Revenue (TTM)
$23.00B
EBITDA (TTM)
$15.95B
EBIT (TTM)
$15.64B
Net Income (TTM)
$14.06B
Balance Sheet
Total Assets (Q)
$26.04B
Total Debt (Q)
$887.00M
Total Liabilities (Q)
$8.06B
Book Value Per Share (Q)
$45.88
Cash Flow
Cash from Operations (TTM)
$9.65B
Cash from Investing (TTM)
-$9.54B
Cash from Financing (TTM)
-$2.84B
Net Change in Cash (TTM)
-$2.73B
Filings
Filing Date
Wednesday, August 3, 2022
Period Date
Thursday, June 30, 2022
Next Filing
Beginning of November (est)
Price History
Loading...
Beta
1.68
7-Day Total Return
-11.84%
30-Day Total Return
14.16%
60-Day Total Return
24.30%
90-Day Total Return
5.63%
Year to Date Total Return
-27.17%
1-Year Total Return
-56.08%
2-Year Total Return
152.37%
3-Year Total Return
1,187.07%
5-Year Total Return
--
52-week Low
Jun 13, 2022 - $115.61
52-week High
Sep 10, 2021 - $464.85
Valuation
Market Cap
$66.97B - Large Cap
Enterprise Value
$49.79B
Price/Sales (TTM)
3.12
Price/Book (Q)
3.73
Dividends and Shares
Shares Outstanding
419.00M
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
www.modernatx.com
Phone Number
617 714 6500
Address
200 Technology Square
Cambridge, MA 02139
Country
United States
Year Founded
2010
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases... more
Weiss Ratings